Pomerantz Law Firm Opens Investor Investigation Into TriSalus Life Sciences
Pomerantz LLP announced on June 18, 2026, that it is investigating claims on behalf of investors of TriSalus Life Sciences Inc., the Nasdaq-listed company trading under the ticker TLSI. The New York-based law firm advised…